- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
BioForce Nanosciences NewsBioForce Nanosciences Secures Additional First-Round Financing
Ames, Iowa. November 11th, 2002
BioForce Nanosciences, Inc., the leading developer of nanoarray biomolecular analysis systems, announced today that a $2,000,000 total equity investment has been received from the Private Equity team of Société Genérale Asset Management, Paris, France, for the first round of financing.
About BioForce NanosciencesBioForce Nanosciences, Inc., is the leading developer of ultra-miniaturized nanoarray technologies for solid-phase, high-throughput molecular analysis systems. The Company is applying its proprietary nanoarray technologies to the areas of protein-protein interaction profiling, disease identification, drug discovery, and to produce applications that are more accurate, less expensive, and faster to perform than conventional methods. About Société Genérale Asset Management
SGAM is the asset management subsidiary of the French Société Générale Group. With over € 272 billion under management as at March 2002, SGAM has international presence, and offers a wide range of clients access to various asset classes in all financial markets. The private equity department manages venture capital funds with a total of € 423 millions for investment in biotechnology and new technologies. SGAM dedicated specialist teams provide start-ups with all the valuable assests and advice from early to mature stages.
BioForce Nanosciences, Inc.
Reprinted with premission. Copyright BioForce Nanosciences, Inc.
If you have a comment, please